MUCOSAL IMMUNITY FOLLOWING ORAL POLIOVIRUS VACCINE AND ENHANCED POTENCY INACTIVATED POLIOVIRUS VACCINE IMMUNIZATION

被引:12
|
作者
MODLIN, JF
机构
[1] Disease Section, Dartmouth Hitchcock Medical Center, Hanover, NH
关键词
MUCOSAL IMMUNITY POLIOVIRUS; ORAL POLIO VIRUS VACCINE; INACTIVATED POLIOVIRUS VACCINE;
D O I
10.1097/00006454-199112000-00031
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mucosal immunity is considered to be an important barrier for inhibiting person-to-person transmission of naturally occurring (wild type) poliovirus infection. This review briefly summarizes the results of a previously published study in which 79 oral poliovirus vaccine (OPV) vaccinated children and 93 enhanced-potency inactivated poliovirus vaccine (IPV) children were challenged with one of two doses of type 1 OPV virus to test the oropharyngeal and gastrointestinal mucosal immunity conferred by each type of poliovirus vaccine. Although both OPV and IPV produced excellent oropharyngeal immunity, OPV was clearly superior in decreasing fecal shedding of the challenge virus.
引用
收藏
页码:976 / 978
页数:3
相关论文
共 50 条
  • [1] Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine - Live attenuated oral poliovirus vaccine immunization schedules
    Modlin, JF
    Halsey, NA
    Thoms, ML
    Meschievitz, CK
    Patriarca, PA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 : S228 - S234
  • [2] Unraveling the Mucosal Immunity of Inactivated Poliovirus Vaccine
    Sutter, Roland W.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (03): : 344 - 346
  • [3] CURRENT ISSUES IN EVALUATING THE EFFICACY OF ORAL POLIOVIRUS VACCINE AND INACTIVATED POLIOVIRUS VACCINE IMMUNIZATION
    PLOTKIN, SA
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (12) : 979 - 981
  • [4] COMPARISON OF ENHANCED POTENCY INACTIVATED POLIOVIRUS VACCINE (EIPV) VERSUS STANDARD ORAL POLIOVIRUS VACCINE (OPV) IN THAI INFANTS
    SIMASATHIEN, S
    MIGASENA, S
    BEUVERY, C
    VANSTEENIS, G
    SAMAKOSES, R
    PITISUTTITHAM, P
    VESIKARI, T
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (06) : 731 - 738
  • [5] Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial
    Snider, Cynthia J.
    Zaman, Khalequ
    Wilkinson, Amanda L.
    Aziz, Asma Binte
    Yunus, Mohammad
    Haque, Warda
    Jones, Kathryn A. V.
    Wei, Ling
    Estivariz, Concepcion F.
    Konopka-Anstadt, Jennifer L.
    Mainou, Bernardo A.
    Patel, Jaymin C.
    Lickness, Jacquelyn S.
    Pallansch, Mark A.
    Wassilak, Steven G. F.
    Oberste, M. Steven
    Anand, Abhijeet
    [J]. VACCINE, 2023, 41 (41) : 6083 - 6092
  • [6] Change from oral poliovirus vaccine to inactivated poliovirus vaccine
    Mele, A
    Jefferson, T
    Franco, E
    Salmaso, S
    [J]. LANCET, 2002, 360 (9340): : 1178 - 1178
  • [7] VACCINATION WITH INACTIVATED POLIOVIRUS VACCINE AND ORAL POLIOVIRUS VACCINE IN DENMARK
    VONMAGNUS, H
    PETERSEN, I
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1984, 6 : S471 - S474
  • [8] EFFICACY AND SAFETY OF ORAL POLIOVIRUS VACCINE AND INACTIVATED POLIOVIRUS VACCINE
    BEALE, AJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (12) : 970 - 972
  • [9] THE HUMORAL IMMUNE-RESPONSE TO TYPE-1 ORAL POLIOVIRUS VACCINE IN CHILDREN PREVIOUSLY IMMUNIZED WITH ENHANCED POTENCY INACTIVATED POLIOVIRUS VACCINE OR LIVE ORAL POLIOVIRUS VACCINE
    MODLIN, JF
    ONORATO, IM
    MCBEAN, AM
    ALBRECHT, P
    THOMS, ML
    NERHOOD, L
    BERNIER, R
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (04): : 480 - 484
  • [10] A mucosal adjuvant for the inactivated poliovirus vaccine
    Steil, Benjamin P.
    Jorquera, Patricia
    Westdijk, Janny
    Bakker, Wilfried A. M.
    Johnston, Robert E.
    Barro, Mario
    [J]. VACCINE, 2014, 32 (05) : 558 - 563